92 related articles for article (PubMed ID: 11226474)
1. A panel immunoblot using co-incubated monoclonal antibodies for identification of melanoma cells.
Wang R; Dworak LJ; Lacy MJ
J Immunol Methods; 2001 Mar; 249(1-2):167-83. PubMed ID: 11226474
[TBL] [Abstract][Full Text] [Related]
2. Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines.
Carrel S; Schreyer M; Schmidt-Kessen A; Mach JP
Hybridoma; 1982; 1(4):387-97. PubMed ID: 6208135
[TBL] [Abstract][Full Text] [Related]
3. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.
Harper JR; Bumol TF; Reisfeld RA
Hybridoma; 1982; 1(4):423-32. PubMed ID: 6208137
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
Saxton RE; Mann BD; Morton DL; Burk MW
Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
[TBL] [Abstract][Full Text] [Related]
5. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
Chen YT; Stockert E; Tsang S; Coplan KA; Old LJ
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8125-9. PubMed ID: 7667256
[TBL] [Abstract][Full Text] [Related]
7. Tissue specificity of anti melanoma monoclonal antibodies analyzed on cell lines.
Johnson JP; Riethmüller G
Hybridoma; 1982; 1(4):381-5. PubMed ID: 6208134
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma.
Brownbridge GG; Gold J; Edward M; MacKie RM
Br J Dermatol; 2001 Feb; 144(2):279-87. PubMed ID: 11251559
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the binding characteristics of monoclonal antimelanoma antibodies.
Herlyn M; Steplewski Z; Atkinson BF; Ernst CS; Koprowski H
Hybridoma; 1982; 1(4):403-11. PubMed ID: 6765323
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma in fine needle aspirates and effusions. An immunocytochemical study using monoclonal antibodies.
Angeli S; Koelma IA; Fleuren GJ; Van Steenis GJ
Acta Cytol; 1988; 32(5):707-12. PubMed ID: 2458662
[TBL] [Abstract][Full Text] [Related]
11. Structural characterization of the 'melanoma-specific' antigen detected by monoclonal antibody 691I5Nu-4-B.
Mitchell KF; Fuhrer JP; Steplewski Z; Koprowski H
Mol Immunol; 1981 Mar; 18(3):207-18. PubMed ID: 6790940
[No Abstract] [Full Text] [Related]
12. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens.
Kantor RR; Ng AK; Giacomini P; Ferrone S
Hybridoma; 1982; 1(4):473-82. PubMed ID: 6208142
[TBL] [Abstract][Full Text] [Related]
13. Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy.
Trefzer U; Hofmann M; Reinke S; Guo YJ; Audring H; Spagnoli G; Sterry W
Melanoma Res; 2006 Apr; 16(2):137-45. PubMed ID: 16567969
[TBL] [Abstract][Full Text] [Related]
14. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
[TBL] [Abstract][Full Text] [Related]
15. Identification and isolation of melanoma-associated antigens with monoclonal antibodies.
Ross AH; Mitchell KF; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(4):413-21. PubMed ID: 6765324
[TBL] [Abstract][Full Text] [Related]
16. Analysis of two human monoclonal antibodies against melanoma.
Yeilding NM; Gerstner C; Kirkwood JM
Int J Cancer; 1992 Dec; 52(6):967-73. PubMed ID: 1459738
[TBL] [Abstract][Full Text] [Related]
17. MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysis.
Dubovsky JA; Albertini MR; McNeel DG
J Immunother; 2007 Oct; 30(7):675-83. PubMed ID: 17893560
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies against human malignant melanoma.
Sorg C; Brüggen J; Suter L; Bröcker EB
Bull Cancer; 1983; 70(2):113-7. PubMed ID: 6871486
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of melanocytic differentiation antigens in cutaneous malignant melanoma. A comparison of six commercial antibodies and one non-commercial antibody in nodular melanoma, superficially spreading melanoma and lentigo maligna melanoma.
Kocan P; Jurkovic I; Böör A; Dudríková K; Krajcár R; Benický M; Kromydaki A
Cesk Patol; 2004 Apr; 40(2):50-6. PubMed ID: 15233017
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen.
Liao SK; Kwong PC; Clarke BJ; Dent PB; Ryan ED; Khosravi MJ; Laferte S; Krantz MJ
J Natl Cancer Inst; 1985 May; 74(5):1047-58. PubMed ID: 2582173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]